Ultrasound Checks of Stomach Contents in People Taking GLP-1 Medicines
Looks at stomach contents by ultrasound in people taking GLP-1 medicines for diabetes or obesity.
Key facts
- Who runs it
- Children's Hospital Medical Center, Cincinnati
- Where
- Cincinnati, United StatesSee the site
- Trial code
- Registry title
- GLP_1 RA Ultrasound Study
- Status
- Enrolling by invitation
- People taking part
- 100 people, planned
- Started
- 8 Jul 2024
- Planned end
- Jul 2026
- Type of study
- Observational, 2 groups
- Treatments tested
- Glucagon-Like Peptide-1 receptor agonists
- Point of Care Gastric Ultrasound
- Record updated
- 7 November 2024
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with type 2 diabetes and a body mass index over 35, some taking a GLP-1 RA drug and some not. It checks how much food is left in the stomach before surgery.
- Age
- 10 Years to 25 Years
- Sex
- All sexes can join.
- Disease stage
- Type 2 diabetes with a body mass index over 35.
- Earlier treatment
- One group is currently taking a GLP-1 RA drug. The control group is not taking one.
Main reasons for not taking part
- Diagnosis of gastroparesis
- Previous gastric bypass or any other gastric surgery
- Currently on peritoneal dialysis
- Abdominal pathology or gastro-intestinal obstruction
- Pregnancy
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Body Mass Index over 35
- Type 2 Diabetes
- Currently taking GLP01 RA agonist (for GLP 1 group)
- Not taking GLP-1 RA agonist (for control group)
Who cannot take part
- Previous gastric bypass or any other gastric surgery
- Currently on peritoneal dialysis
- Diagnosis of gastroparesis
- patient refusal to participate
- Abdominal pathology
- Gastro-intestinal obstruction
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 10 and 25 years old?
Where in United States
- Cincinnati Children's HospitalCincinnati, United StatesEnrolling by invitation
About the trial
What the trial wants to find out
The purpose of the study is to determine whether patients taking GLP-1 RAs have increased residual (left behind), gastric (stomach), contents due to delayed gastric emptying when following standard preoperative fasting guidelines.
The 2 groups in the trial
- GLP-1
Individuals currently taking glucagon like peptide receptors who have a surgery scheduled with Cincinnati Children's Hospital same day surgery endocrinology clinic and will receive a point of care gastric ultrasound.
Treatment: Glucagon-Like Peptide-1 receptor agonists and Point of Care Gastric Ultrasound
- Control
Individuals not taking GLP-1 who have a surgery scheduled with Cincinnati Children's Hospital same day surgery or endocrinology clinic and will receive a point of care gastric ultrasound.
Treatment: Point of Care Gastric Ultrasound
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Assessment of Gastric Contents in Patients Taking Glucagon-Like Peptide-1 Receptor Agonists: a Prospective Observational Cross-sectional Study
- Plain-language title
- Ultrasound Checks of Stomach Contents in People Taking GLP-1 MedicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06581120, who can take part
- Record updated
- 7 November 2024